MIRA MIRA
Company Profile ↓Company Overview
MIRA (MIRA) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -58.11% |
| 6 Months: | -44.73% |
| 3 Months: | -35.52% |
| 1 Month: | -30.62% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)26.48 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 63.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1.48M | -2.42M | -1.81M | -1.34M | -1.27M | -3.59M | -1.72M | -1.69M | -2.04M | -1.78M | -1.54M | -1.14M | -1.15M |
| Diluted EPS | - | -0.19 | -0.14 | -0.10 | -0.10 | -0.26 | -0.15 | -0.11 | -0.14 | -0.11 | -0.09 | -1.18 | -0.03 |
| R&D Expense | - | - | 714.97K | 271.61K | -101.02K | 1.02M | 762.28K | 614.46K | 1.07M | 314.40K | 496.20K | 412.64K | 524.78K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 7.05M | 8.53M | 8.02M | 10.49M |
| Operating Income | - | -7.05M | -8.53M | -8.02M | -10.49M |
| EBITDA | - | -7.05M | -8.53M | -8.02M | -10.49M |
| Interest Expense | 24.37K | 10.25K | 3.46M | - | - |
| Pretax Income | - | -7.06M | -11.98M | -7.85M | -10.44M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -7.06M | -11.98M | -7.85M | -10.44M |
| Diluted EPS | - | -0.40 | -0.85 | -0.51 | -1.35 |
| R&D Expense | - | 2.35M | 1.57M | 3.31M | 1.72M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 858.07K | 4.93M | 2.92M | 11.09M |
| Total Equity | 2.26M | -596.23K | 4.37M | 2.20M | 10.39M |
| Cash & Equivalents | - | - | - | 2.83M | 6.35M |
| Total Liabilities | - | 1.45M | 558.10K | 723.35K | 702.07K |
| Current Liabilities | - | 1.37M | 558.10K | 723.35K | 702.07K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -5.60M | -4.53M | -5.56M | -4.66M |
| Financing Cash Flow | 3.15M | 8.78M | 3.79M | 8.18M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | 1,183.8% | -273.9% | -357.0% | -100.5% |
| ROCE % | - | 1,376.6% | -194.9% | -364.5% | -101.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MIRA
Market Movers | Winners: AEMD, HYFM, FUSE | Losers: GYGY, CALC, MIRA - Trefis
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxONmpZejhMN1plVjVocTU4ZFo2M1c3ajlfbkppWmszcmdQSTZrUG9qS1A0MS1peFlVeVVfZ2RZZXBzSUNjVDUwZ3l2SUtMRjREOEp3THZTRllyV29NMmExZjY0c2h3X09xb2tfNUxDTEtaNjVwVFJBaUJHQ200aldZcENNR21feEhTQmExQ2…
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMnd4M3ZxdkFMZUo2SjJ4OFR3R3ZybDNEcG0tRS00YWNVQkROaXVMLTBLQUR2Tmh3SnYyd01QcnZqS1pqVXZsUUxzaWxZVjFiME9YZHJtUGhKdUZvcGpzbXhrRDBLc1I3dWdyWXh0UXFIYW8wVE9tWjktOUR0b3ZleXdvMWwyNlhNOHpwT0…
Tangible book value per share of MIRA Pharmaceuticals, Inc. – MUN:K6S - TradingView
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQUTdPaWVPNXNDT0QwbHJpaHJydFRwZ2dKR09ZRUJrUlRMQmY4aGd4akE1T0JRbEZsb01ZeG9GV2t6ek9EUzVFM3BRWXRyeUxnQTlNOEtEb1lhcGxSM3Z0T0xaM3ZTS0ZyOGx1b1dPQjEwajFUT1Z1UTA3M3VZdDZ4bGJRQ0xPZXVMQzRycn…
MIRA's Two Oral Drug Candidates Finish Dosing in Rats and Dogs - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQVm5MUVhvOHpBV0cxZHBCOEJfeFZwbVZ2WE11enhQYm9tclR2Y3RSdXctQXZMN3ZjdG9TWEhLNDFHMV9ubDlaMnJQelA5Nll2ZGp4Y0ZhQm9Fa09XTlVQdkxkaFZUQU1oSmxuR1ExZVhySlNGOUhUaDkxYmxWdmdYcWU5ME1UMDNGc1VvdF…
MIRA|Mira Pharmaceuticals Inc|Price:0.792|Chg%:-0.012 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9nQnRRQjBFak1RUmo3UU55d3J6ZmJORjg2YW9TaWV3TlMxVDRRZE12Y1BVV2JsQlRVcFBjeF9ldDltblJMRzBRQTRVWGcwVGl3SVNYZmNlVmhmeC1SU3FTM0c2Q0I5TGRHb09jbVB3?oc=5" target="_blank">MIRA|Mira Pharmaceu…
MIRA Pharmaceuticals completes toxicology studies for two candidates By Investing.com - Investing.com UK
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxOcnNWalZYRUlWZUlVOVAySWstMWNfZjkycjBMVTF6S3k3Uk1VdEdUOW4wcjNNNlNPUS1xMkM4bVFvSExSX1lhYXB6dnpWVWx2TVJId2RQVEk3RWtVTm9UNGFzNlJJOC1kYjA3cEQ3dXp4S1RhVFhlV2UyM0hkZG1XMkRBMzYwdHZvRmF3a1…
MIRA — Frequently Asked Questions
What is the current share price of MIRA?
As of 2026-08-05 17:25 PDT, MIRA trades at $0.66 on NASDAQ/NYSE. Its 52-week range is $0.61 to $1.80.
What is the P/E ratio of MIRA?
MIRA trades at a trailing price-to-earnings (P/E) ratio of -0.49.
What is the return on equity (ROE) of MIRA?
MIRA has a return on equity (ROE) of -100.49%. Its return on capital employed (ROCE) is -100.98%.
Is MIRA a good stock to buy?
This page provides a data-driven analysis of MIRA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.